ENBIO HOLDINGS, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 620 JPY | +0.98% |
|
+2.14% | +4.38% |
| 20/06 | EnBio Holdings, Inc announces an Equity Buyback for 60,000 shares, representing 0.74% for ¥35 million. | CI |
| 20/06 | EnBio Holdings, Inc authorizes a Buyback Plan. | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 13,256 | 4,140 | 3,680 | 4,223 | 5,517 | 5,039 |
| Enterprise Value (EV) 1 | 21,905 | 13,697 | 8,801 | 11,243 | 11,727 | 11,107 |
| P/E ratio | 30.4 x | -27.5 x | 6.7 x | 14 x | 8.43 x | 6.21 x |
| Yield | - | - | - | - | 0.96% | 1.05% |
| Capitalization / Revenue | 1.58 x | 0.48 x | 0.5 x | 0.62 x | 0.61 x | 0.62 x |
| EV / Revenue | 2.61 x | 1.6 x | 1.19 x | 1.64 x | 1.3 x | 1.37 x |
| EV / EBITDA | 19.3 x | 12 x | 8 x | 11.4 x | 7.4 x | 6.32 x |
| EV / FCF | -5.08 x | -14.3 x | 10.8 x | -6.58 x | 13.1 x | -18.6 x |
| FCF Yield | -19.7% | -7% | 9.23% | -15.2% | 7.61% | -5.37% |
| Price to Book | 2.94 x | 0.96 x | 0.75 x | 0.81 x | 0.94 x | 0.74 x |
| Nbr of stocks (in thousands) | 6,438 | 6,499 | 6,571 | 6,578 | 6,647 | 6,638 |
| Reference price 2 | 2,059 | 637.0 | 560.0 | 642.0 | 830.0 | 759.0 |
| Announcement Date | 25/06/18 | 24/06/19 | 29/06/20 | 28/06/21 | 27/06/22 | 28/06/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 8,388 | 8,563 | 7,408 | 6,840 | 8,987 | 8,120 |
| EBITDA 1 | 1,136 | 1,145 | 1,100 | 985 | 1,585 | 1,758 |
| EBIT 1 | 787 | 637 | 674 | 618 | 1,244 | 1,358 |
| Operating Margin | 9.38% | 7.44% | 9.1% | 9.04% | 13.84% | 16.72% |
| Earnings before Tax (EBT) 1 | 650 | -60 | 833 | 488 | 1,098 | 1,233 |
| Net income 1 | 403 | -150 | 555 | 304 | 654 | 812 |
| Net margin | 4.8% | -1.75% | 7.49% | 4.44% | 7.28% | 10% |
| EPS 2 | 67.81 | -23.21 | 83.64 | 45.76 | 98.47 | 122.3 |
| Free Cash Flow 1 | -4,311 | -958.4 | 812 | -1,709 | 892.6 | -596.8 |
| FCF margin | -51.39% | -11.19% | 10.96% | -24.98% | 9.93% | -7.35% |
| FCF Conversion (EBITDA) | - | - | 73.82% | - | 56.32% | - |
| FCF Conversion (Net income) | - | - | 146.31% | - | 136.49% | - |
| Dividend per Share | - | - | - | - | 8.000 | 8.000 |
| Announcement Date | 25/06/18 | 24/06/19 | 29/06/20 | 28/06/21 | 27/06/22 | 28/06/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,287 | 3,621 | 4,301 | 3,039 | 2,668 | 5,636 | 1,135 | 3,423 | 5,482 | 1,504 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 626 | 410 | 702 | 368 | 715 | 1,378 | -18 | 240 | 409 | 58 |
| Operating Margin | 14.6% | 11.32% | 16.32% | 12.11% | 26.8% | 24.45% | -1.59% | 7.01% | 7.46% | 3.86% |
| Earnings before Tax (EBT) 1 | 829 | 394 | 581 | 379 | 732 | 1,451 | -161 | 345 | 547 | -3 |
| Net income 1 | 523 | 263 | 375 | 205 | 480 | 972 | -116 | 170 | 321 | 24 |
| Net margin | 12.2% | 7.26% | 8.72% | 6.75% | 17.99% | 17.25% | -10.22% | 4.97% | 5.86% | 1.6% |
| EPS 2 | 80.14 | 40.15 | 56.62 | 30.90 | 72.28 | 146.4 | -17.45 | 22.79 | 41.11 | 2.450 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 13/11/19 | 13/11/20 | 12/11/21 | 14/02/22 | 12/08/22 | 14/11/22 | 13/02/23 | 14/08/23 | 14/11/23 | 14/02/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 8,649 | 9,557 | 5,121 | 7,020 | 6,210 | 6,068 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 7.614 x | 8.347 x | 4.655 x | 7.127 x | 3.918 x | 3.452 x |
| Free Cash Flow 1 | -4,311 | -958 | 812 | -1,709 | 893 | -597 |
| ROE (net income / shareholders' equity) | 11.4% | -3.49% | 11.5% | 6.49% | 12.5% | 12.4% |
| ROA (Net income/ Total Assets) | 3.15% | 2.14% | 2.54% | 2.51% | 4.85% | 5.03% |
| Assets 1 | 12,786 | -7,002 | 21,815 | 12,094 | 13,487 | 16,130 |
| Book Value Per Share 2 | 699.0 | 666.0 | 744.0 | 795.0 | 886.0 | 1,023 |
| Cash Flow per Share 2 | 546.0 | 360.0 | 454.0 | 303.0 | 357.0 | 426.0 |
| Capex 1 | 4,641 | 627 | 357 | 1,729 | 1,164 | 1,162 |
| Capex / Sales | 55.33% | 7.32% | 4.82% | 25.28% | 12.95% | 14.31% |
| Announcement Date | 25/06/18 | 24/06/19 | 29/06/20 | 28/06/21 | 27/06/22 | 28/06/23 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +4.38% | 31.28M | |
| +2.68% | 239M | |
| +38.63% | 231M | |
| -44.65% | 192M | |
| -14.47% | 117M | |
| +36.25% | 106M |
- Stock Market
- Equities
- 6092 Stock
- Financials EnBio Holdings, Inc
